Skip to main content
Premium Trial:

Request an Annual Quote

LifeSpan Signs Aventis as Subscriber to GPCR Database

NEW YORK, Oct. 9 – LifeSpan BioSciences of Seattle said Tuesday it had signed Aventis Pharma as its sixth subscriber to its G protein-coupled receptors database.

The database Lifespan will provide to Aventis of Strasbourg, France, includes information on non-olfactory GPCRs. The database, which is designed to help users to identify and prioritize potential drug targets, was designed to be used by Aventis’ branches in the US, Germany, and France.

"We are now mapping the top 320 GPCRs of potential therapeutic interest,” Joseph Brown, CEO of LifeSpan BioSciences, said in a statement. 

GPCRs comprise a family of cell-surface molecules that act as receptors for many biologically active compounds and pharmaceuticals. 

LifeSpan’s other subscribers are Pfizer, Merck, Bristol-Myers Squibb, Novartis Research Foundation, and Sanofi-Snythelabo.

Financial terms of the deal were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.